학술논문
Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trial
Document Type
article
Author
Sten M. M. van Beek; Yvonne M. H. Bruls; Froukje Vanweert; Ciarán E. Fealy; Niels J. Connell; Gert Schaart; Esther Moonen-Kornips; Johanna A. Jörgensen; Frédéric M. Vaz; Ellen T. H. C. Smeets; Peter J. Joris; Anne Gemmink; Riekelt H. Houtkooper; Matthijs K. C. Hesselink; Tore Bengtsson; Bas Havekes; Patrick Schrauwen; Joris Hoeks
Source
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Subject
Language
English
ISSN
2041-1723
Abstract
β2-agonist treatment improves skeletal muscle glucose uptake and whole-body glucose homeostasis in rodents. Here the authors report that two-weeks of treatment with the β2-agonist clenbuterol improves insulin-stimulated glucose disposal in healthy young men in a double-blinded, randomized cross-over trial.